Medicure (MCUJF) Cash & Equivalents (2009 - 2026)

Medicure's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 77.64% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 77.64% YoY), while the FY2025 annual figure was $2.7 million, down 47.74% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $1.1 million, down from $2.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $5.1 million in Q4 2024, with the low at $1.1 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $3.6 million (2023), against an average of $3.7 million.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents jumped 89.34% in 2022, then slumped 77.64% in 2026.
• Medicure's Cash & Equivalents stood at $3.6 million in 2022, then soared by 30.74% to $4.7 million in 2023, then climbed by 10.03% to $5.1 million in 2024, then slumped by 46.58% to $2.8 million in 2025, then sank by 59.11% to $1.1 million in 2026.
• Business Quant data shows MCUJF's Cash & Equivalents at $1.1 million in Q1 2026, $2.8 million in Q4 2025, and $3.0 million in Q3 2025.